Vertex Pharmaceuticals, Inc.
(NASDAQ : VRTX)

( )
VRTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 3.15%454.600.0%$6127.57m
BNTXBioNTech SE 4.05%352.990.0%$1059.79m
NVAXNovavax, Inc. 10.90%257.3079.4%$994.94m
SNSSSunesis Pharmaceuticals, Inc. 2.00%8.690.7%$607.46m
AMGNAmgen, Inc. 0.66%215.051.4%$556.80m
GILDGilead Sciences, Inc. 0.43%71.691.0%$457.92m
REGNRegeneron Pharmaceuticals, Inc. -0.09%646.512.7%$422.03m
TECHBio-Techne Corp. 0.73%536.904.5%$370.97m
ILMNIllumina, Inc. -0.32%433.203.5%$350.21m
BIIBBiogen, Inc. 1.34%293.201.7%$310.59m
VRTXVertex Pharmaceuticals, Inc. 0.45%185.091.9%$247.51m
ISEEIVERIC bio, Inc. 1.44%16.230.0%$190.62m
LIFEaTyr Pharma, Inc. 8.33%12.482.1%$188.70m
DVAXDynavax Technologies Corp. 4.31%19.605.7%$160.10m
BGNEBeiGene Ltd. -0.71%385.421.3%$145.35m

Company Profile

Vertex Pharmaceuticals, Inc. is a global biotechnology company. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.